Cellular automata are discrete models made up of a grid of cells, where each cell can occupy a limited number of states. The state of each cell changes at distinct time intervals according to a set of established rules that consider the states of adjacent cells. Despite the simplicity of the rules, these systems can generate intricate and emergent patterns and behaviors. Ultimately, cellular automata can simulate a wide variety of real-world systems, including physical processes like fluid dynamics, biological phenomena such as the spread of diseases, and the growth of populations of any kind.
This is our latest selection of worldwide publications and patents in english on Cellular Automata, between many scientific online journals, classified and focused on cellular automata, cellular automaton, automata theory, cellular space, tessellation automata, iterative array, Stanislaw Ulam, tessellation structure, cellular structure, John von Neumann, game of life, Conway, homogeneous structure, Stephen Wolfram, turing-complete and automata.
Publication: no recent news on this particular topic. Please try the extensive manual search in the Publication Database linked just above.
Molecular jackhammer for mechanical destruction of cellular structure
Patent published on the 2025-05-29 in US under Ref US2025170098 by NANOROBOTICS LTD [IL] (Ayala-orozco Ciceron [us], Tour James M [us], Li Gang [us], Li Bowen [us])
Abstract: In one aspect, the present disclosure describes methods which may be used to disrupt cellular membranes. These compounds may generate a vibronic-driven action when exposed to a sufficient energy source and that action may be used to disrupt the membrane of a cell or other organism. Also described are compounds and uses thereof.[...]
Our summary: Methods for disrupting cellular membranes using vibronic-driven compounds, compounds for disrupting cell membranes, uses of compounds for cellular destruction.
molecular, jackhammer, mechanical destruction, cellular structure
Patent
Rationally-designed synthetic peptide shuttle agents for delivering polypeptide cargos from an extracellular space to the cytosol and/or nucleus of a
Patent published on the 2025-05-21 in EP under Ref EP4556567 by FELDAN BIO INC [CA] (Del'guidice Thomas [ca], Lepetit-stoffaes Jean-pascal [ca], Guay David [ca])
Abstract: The present description relates to methods for delivering polypeptide cargos from an extracellular space to the cytosol and/or nucleus of a target eukaryotic cell. The methods involve contacting the cell with the polypeptide cargo in the presence of a peptide shuttle agent at a concentration sufficient to increase the polypeptide cargo's transduction efficiency. Also described here are parameters that may be used in the rational design of such synthetic peptide shuttle agents, peptide shuttle ag[...]
Our summary: Methods for delivering polypeptide cargos using synthetic peptide shuttle agents to increase transduction efficiency in target eukaryotic cells. Parameters for rational design, shuttle agents satisfying design parameters, and compositions for delivering various polypeptide cargos are also discussed. Applications and targets for genome-editing NK cells for improved immunotherapy are included.
synthetic peptide, shuttle agents, polypeptide cargos, transduction efficiency
Patent
Ocular photo-bio-stimulation optics
Patent published on the 2025-03-13 in WO under Ref WO2025054569 by NEURORAYS LLC [US] (Blum Ronald [us], Broach Anita [us], Loeb Jack [us])
Abstract: A device providing ocular photo-bio-stimulation therapy, a biological technique to control or influence the activity of neurons or other cell types in, on or about the eye with light. As used herein ocular photo-bio-stimulation is an umbrella category of which photobiomodulation, optogenetics and phototherapy are forms thereof. The current invention relates, in part, to photobiomodulation therapy, which includes the utilization of nonionizing electromagnetic energy to trigger photochemical chang[...]
Our summary: Device providing ocular photo-bio-stimulation therapy using light to control neuron activity. Umbrella category including photobiomodulation, optogenetics, and phototherapy. Utilizes nonionizing electromagnetic energy for cellular changes.
ocular, photo-bio-stimulation, optics, therapy
Patent
Ocular photo-bio-stimulation optics
Patent published on the 2025-03-13 in WO under Ref WO2025054570 by NEURORAYS LLC [US] (Blum Ronald [us], Broach Anita [us], Loeb Jack [us])
Abstract: A device providing ocular photo-bio-stimulation therapy, a biological technique to control or influence the activity of neurons or other cell types in, on or about the eye with light. As used herein ocular photo-bio-stimulation is an umbrella category of which photobiomodulation, optogenetics and phototherapy are forms thereof. The current invention relates, in part, to photobiomodulation therapy, which includes the utilization of nonionizing electromagnetic energy to trigger photochemical chang[...]
Our summary: Ocular photo-bio-stimulation optics device for therapy using light to control neuron activity. Umbrella category includes photobiomodulation, optogenetics, and phototherapy. Invention utilizes nonionizing electromagnetic energy for cellular changes.
photo-bio-stimulation, optics, photobiomodulation, optogenetics
Patent
Related Posts
Risk–benefit Ratio In Risk Assessment
Best Engineer Jokes (and Designers, Creators, Marketers …)
The 5 Capability Maturity Model Integration (CMMI) Levels
Industrial Internet Of Things (IIoT)
Innovation.world’s Concept Explorer™
Programming Languages For Engineering, Science And Research – Full Comparison